世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033193

イギリスの臨床化学および免疫診断分析装置・試薬(2022年):乱用薬物検査、癌検査、化学検査、内分泌検査、免疫タンパク質検査、TDMなど100種類 ‐ サプライヤーの高成長機会、競合のシェアと成長戦略、2026年までの数量・売上セグメント予測、最新技術・計測器パイプライン

VPGMarketResearch

2022 UK Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

発刊日 2022/09/27

言語英語

体裁PDF

ライセンス/価格

0000033193

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、イギリスの免疫診断市場で今後5年間に出現する主なビジネスチャンスを調査したものです。

レポートはセクションごとに提供され、特定の情報ニーズや予算に合わせてカスタマイズすることができます。本レポートでは、イギリス市場の将来動向を探り、検体量、検査量、販売量、主要サプライヤーの売上と市場シェアの推定を行い、主要分析装置の特徴の比較、主要競合企業のプロファイル、今後5年間に出現する特定の製品とマーケティングの機会の特定を行っています。

本レポートは、病院、商業試験所、医院、外来診療センターで実施される100以上の臨床化学、TDM、内分泌、癌、免疫タンパク質、乱用薬物アッセイについて、コントロール、キャリブレーター、消耗品を含む5年間の数量および売上高の予測を示しています。

論理的根拠

臨床化学および免疫診断の市場は、新しい、より厳しい規制、診断技術、システムエンジニアリング、自動化、ITの進歩、そして競争の激化により、大きな変革期を迎えています。ルーチンケミストリーのように、製品の位置づけや検査単価が基本技術よりも重要な、すでにコモディティ市場に近い分野もあります。このように進化する市場は、様々な新しい装置、試薬システム、そして検体準備装置、コントロール、キャリブレーターなどの補助製品にとって、エキサイティングな機会を生み出します。

調査範囲

  • イギリス市場の概要
    ➣ 臨床化学および免疫診断検査を実施する施設の推定値
    ➣ 検査件数と販売予測
  • 戦略的な提言
    ➣ 市場で大きな魅力を持つ新製品開発の機会
    ➣ 市場浸透のための代替戦略
    ➣ 潜在的な市場参入障壁とリスク
  • 市場セグメント分析
    ➣ 市場力学、動向、構造、規模、成長、主要サプライヤーの包括的なレビュー
    ➣ 以下の市場セグメント別の100種類以上の臨床化学、TDM、内分泌、癌、免疫タンパク質、乱用薬物アッセイの検査量と売上予測
      ◇ 病院
      ◇ 商業/私立研究所
  • 本レポートで分析した個別検査
    ルーチン臨床化学
    アルブミン、アルカリホスファターゼ、ALT/SGPT、アンモニア、アミラーゼ、AST/SGOT、ビリルビン(直接)、ビリルビン(トータル)、BNP、BUN(血中尿素窒素)、カルシウム、二酸化炭素/重炭酸塩、心臓CRP、塩化物、コレステロール、 クレアチンキナーゼ(CK)、CK-MB、クレアチニン、CRP、シスタチン C、フェリチン、フルクトサミン、GGT、グルコース、HDL コレステロール、ホモシステイン、hs-CRP、インスリン、鉄、鉄(総結合容量)、鉄(不飽和結合容量)、LDH、LDLコレステロール、LDLコレステロールダイレクト、リパーゼ、リポプロテインa、マグネシウム、マイクロアルブミン、NT-proBNP、リン、カリウム、ナトリウム、ST2、総タンパク質、トリグリセリド、トロポニン、尿酸
    薬物治療モニタリング
    アミカシン、カルバマゼピン、シクロスポリン、ジゴキシン、エベロリムス、ゲンタマイシン、レベチラセタム、リチウム、メトトレキサート、NAPA/プロカインアミド、フェノバルビタール、フェニトイン、キニジン、シロリムス、タクロリムス、テオフィリン、トブラマイシン、トピリメート、バルプロ酸、バンコマイシン
    内分泌機能
    コルチゾール、エストラジオール、FSH、HCG、ガストリン、LH、プロゲステロン、PTH/IO PTH、プロラクチン、T3、T3フリー、T3取り込み、T4、T4フリー、TBG、テストステロン、チログロブリン抗体、TPO抗体、TSH
    腫瘍マーカーと特殊化学
    AFP、CA 15-3/27-29、CA 19-9、CEA、フェリチン、葉酸、グリコシル化ヘモグロビン、HCG、25-ヒドロキシ ビタミンD2 およびD3、潜血、PAP、PSA、チログロブリン、ビタミンB -12
    免疫タンパク質
    C3、C4、遊離軽鎖、ハプトグロビン、IgA、IgE 特異的、IgE 合計、IgG、IgM、免疫固定、プレアルブミン、タンパク質電気泳動
    乱用薬物
    アンフェタミン、抗うつ薬、バルビツール酸、ベンゾジアゼピン、カンナビノイド/マリファナ、コカイン、LSD、メタドン、メタクアロン、アヘン、フェンシクリジン(PCP)、プロポキシフェン、三環系抗うつ薬
  • 現行製品および新製品
    ➣ 現在および新たな臨床化学および免疫診断検査の分析
    ➣ 現在の計測技術のレビューと、大容量、中容量、および低容量/POC 分析装置の機能比較
  • 技術レビュー
    ➣ 現在の技術や新しい技術、およびそれらの潜在的な市場アプリケーションの評価
    ➣ 検査別の新技術・新製品の開発・販売企業
  • 競合評価
    ➣ 主要サプライヤーおよび新興市場参入企業の戦略的評価(売上、製品ポートフォリオ、マーケティング戦術、提携関係、研究開発中の新製品など)
  • 調査企業
    ➣ Abbott Laboratories
    ➣ Agilent Technologies
    ➣ Beckman Coulter/Danaher
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ DiaSorin
    ➣ 栄研化学(Eiken Chemical)
    ➣ 富士レビオ(Fujirebio)
    ➣ Grifols
    ➣ Instrumentation Laboratory/Werfen
    ➣ 協和メデックス(Kyowa Medex)
    ➣ Ortho-Clinical Diagnostics
    ➣ PerkinElmer
    ➣ Quest Diagnostics
    ➣ Roche
    ➣ Siemens Healthineers
    ➣ Sysmex
    ➣ Thermo Fisher
    ➣ 東ソー(Tosoh)
    ➣ Wako

レポート詳細

目次

Table of Contents

I. Introduction

II. Market Overview
 1. Business Environment
 2. Market Structure
 3. Market Size and Growth

III. Major Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Market and Technology Overview
A. Major Routine Chemistry Tests
 1. Albumin
 2. Alkaline Phosphatase
 3. ALT/SGPT
 4. Ammonia
 5. Amylase
 6. AST/SGOT
 7. Bilirubin, Total
 8. Blood Gases
 9. Blood Urea Nitrogen (BUN)
 10. Calcium
 11. Cardio CRP
 12. Cholesterol
 13. Cholinesterase
 14. CRP
 15. Creatinine
 16. Electrolytes
  a. Carbon Dioxide/Bicarbonate
  b. Chloride
  c. Potassium
  d. Sodium
 17. Ferritin
 18. Fructosamine
 19. Gamma-Glutamyl Transpeptidase (GGT)
 20. Glucose
 21. High Density Lipoprotein (HDL)
 22. Homocysteine
 23. Iron
 24. Lactate Dehydrogenase (LDH)
 25. Magnesium
 26. Phosphorus
 27. Protein
 28. Triglycerides
 29. Uric Acid
 30. Troponin
B. Therapeutic Drug Monitoring (TDM)
 1. Overview
 2. Carbamazepine
 3. Cyclosporin
 4. Digoxin
 5. Everolimus
 6. Gentamicin
 7. Lamotrigine/Lamictal
 8. Levetiracetam
 9. Lidocaine
 10. Lithium
 11. NAPA/Procainamide
 12. Phenytoin
 13. Quinidine
 14. Sirolimus
 15. Tacrolimus
 16. Theophylline
 17. Topirimate
 18. Valproic Acid
C. Endocrine Function Tests
 1. Cortisol
 2. Estradiol
 3. Follicle-Stimulating Hormone (FSH)
 4. Gastrin
 5. Growth Hormone/IGF-1
 6. Human Chorionic Gonadotropin (HCG)
 7. LH
 8. Progesterone
 9. PTH/IO PTH
 10. Prolactin
 11. T3
 12. T3 Free
 13. T3 Uptake
 14. T4 (Thyroxine)
 15. T4 Free
 16. TBG
 17. Testosterone
 18. Thyroglobulin Ab
 19. TPO Ab
 20. TSH
D. Tumor Markers and Special Chemistry Tests
 1. AFP
 2. CA 15-3
 3. CA 19-9
 4. CA 27-29
 5. Carcinoembrionic Antigen (CEA)
 6. Folate/Folic Acid
 7. HCG
 8. 25-Hydroxy Vitamin D2 and D3
 9. Occult Blood
 10. Prostate-Specific Antigen (PSA)
 11. Thyroglobulin
 12. Vitamin B-12
E. Immunoprotein Tests
 1. Complement
  a. C3
  b. C4
 2. Free Light Chains
 3. Immunofixation
 4. Immunoglobulins (IgA, IgE, IgG, IgM)
 5. Haptoglobin
 6. Prealbumin
 7. Protein Electrophoresis
F. Drugs of Abuse
 1. Overview
 2. Test Methodologies
 3. Amphetamines
 4. Barbiturates
 5. Benzodiazepines
 6. Cannabinoids/Marijuana
 7. Cocaine
 8. Lysergic Acid Diethylamide (LSD)
 9. Methadone
 10. Methaqualone
 11. Opiates
 12. Phencyclidine
 13. Tricyclic Antidepressants
G. Clinical Chemistry and Immunodiagnostic Instrumentation Review:
operating characteristics and features of high-, medium-, and low-volume/POC analyzers
H. Major Cliinical Chemistry and Immunodiagnostic Technologies and Their Potential Applications
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 3. Tandem Mass Spec
 4. IT and Automation
 5. Dry Chemistry
 6. Biosensors

VIII. U.K. Clinical Chemistry and Immunodiagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument, Reagent Sales and Market Shares

IX. Competitive Assessments
 - Abbott Laboratories
 - Agilent Technologies
 - Beckman Coulter/Danaher
 - bioMerieux
 - Bio-Rad
 - DiaSorin
 - Eiken Chemical
 - Fujirebio
 - Grifols
 - Instrumentation Laboratory/Werfen
 - Kyowa Medex
 - Ortho-Clinical Diagnostics
 - PerkinElmer
 - Quest Diagnostics
 - Roche
 - Siemens Healthineers
 - Sysmex
 - Thermo Fisher
 - Tosoh
 - Wako

List of Tables
Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests
Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin/Dilantin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Acid Tests
Major Companies Developing or Marketing
FSH Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
LH Tests
Major Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests
Major Companies Developing or Marketing
CRP Tests
Major Companies Developing or Marketing
Drugs of Abuse Tests
Major Companies Developing or Marketing
Biosensors for Immunological Testing
Executive Summary Table: U.K., Clinical
Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
U.K., Laboratories Performing Chemistry and Immunoassay Testing By Market Segment
U.K., Hospital Laboratories Performing
Chemistry and Immunoassay Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Chemistry and Immunoassay Tests by Annual Test Volume
U.K., Total Chemistry and Immunoassay
Specimen Volume Forecast
U.K., All Market Segments, Specimen Volume
Forecast By Test Category
U.K., Total Clinical Chemistry and Immunoassay
Test Volume Forecast By Test Category
U.K., Routine Chemistry Test Volume
Forecast By Market Segment
U.K., Endocrine Function Test Volume
Forecast By Market Segment
U.K., Tumor Markers and Special Chemistry
Test Volume Forecast By Market Segment
U.K., Immunoprotein Test Volume
Forecast By Market Segment
U.K., TDM Test Volume Forecast by Market Segment
U.K., Drugs of Abuse Test Volume
Forecast By Market Segment
U.K., All Market Segments, Profiles, Panels and Individual Tests Forecast
U.K., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
U.K., Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
U.K., All Market Segments, Routine
Chemistry Test Volume Forecast by Assay
U.K., Hospital Laboratories, Routine
Chemistry Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay
U.K., All Market Segments, Endocrine
Function Test Volume Forecast by Assay
U.K., Hospital Laboratories, Endocrine
Function Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Endocrine Function Test Volume
Forecast by Assay
U.K., All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test
Volume Forecast by Assay
U.K., All Market Segments, Immunoprotein
Test Volume Forecast by Assay
U.K., Hospital Laboratories, Immunoprotein
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by Assay
U.K., All Market Segments, TDM
Test Volume Forecast by Assay by Assay
U.K., Hospital Laboratories, TDM
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
U.K., All Market Segments, Drugs
of Abuse Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs
of Abuse Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Total Clinical Chemistry and Immunoassay
Reagent Market Forecast By Test Category
U.K., Clinical Chemistry and Immunoassay
Calibrator and Control Market Forecast by Test Category
U.K., Routine Chemistry Reagent Market
Forecast By Market Segment
U.K., Endocrine Function Reagent Market
Forecast By Market Segment
U.K., Tumor Markers and Special Chemistry
Reagent Market Forecast By Market Segment
U.K., Immunoprotein Reagent Market
Forecast By Market Segment
U.K., TDM Reagent Market Forecast by Market Segment
U.K., Drugs of Abuse Reagent Market
Forecast By Market Segment
U.K., All Market Segments, Routine Chemistry
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Routine Chemistry
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Routine Chemistry
Reagent Market Forecast by Assay
U.K., All Market Segments, Endocrine Function
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Endocrine Function
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Endocrine Function
Reagent Market Forecast by Assay
U.K., All Market Segments, Immunoprotein
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Immunoprotein
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Immunoprotein
Reagent Market Forecast by Assay
U.K., All Market Segments, TDM
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, TDM
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.K., All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent
Market Forecast by Assay
U.K., All Market Segments, Drugs of
Abuse Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of
Abuse Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Clinical Chemistry and Immunoassay
Instrument Market Forecast By Analyzer Type
U.K., Major Suppliers of Clinical Chemistry
Diagnostic Products, Estimated Sales and Market Shares
U.K., Major Suppliers of Immunoassay
Diagnostic Products, Estimated Sales and Market Shares

この商品のレポートナンバー

0000033193

TOP